Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Miller

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 3: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonistsGregory A Gfesser, Henry Zhang, Jurgen Dinges, et al.
Journal of Medicinal Chemistry|August 8, 2008
The alkaloid conessine and analogues as potent histamine H3 receptor antagonistsChen Zhao, Minghua Sun, Youssef L Bennani, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 4, 2008
Emergency department utilization patterns among older adultsFredric D Wolinsky, Li Liu, Thomas R Miller, et al.
Chiropractic & Osteopathy|September 8, 2007
The use of chiropractors by older adults in the United StatesFredric D Wolinsky, Li Liu, Thomas R Miller, et al.
Biochemical Pharmacology|August 6, 2004
Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonistTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like propertiesTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
Neuropharmacology|July 5, 2005
2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonistMasaki Nakane, Marlon D Cowart, Gin C Hsieh, et al.
Pharmacology, Biochemistry, and Behavior|December 17, 2009
H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in ratsGin C Hsieh, Prasant Chandran, Anita K Salyers, et al.
Journal of Medicinal Chemistry|September 27, 2008
Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation modelsMarlon D Cowart, Robert J Altenbach, Huaqing Liu, et al.
Journal of Medicinal Chemistry|October 9, 2007
Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonistsRobert J Altenbach, Huaqing Liu, Patricia N Banfor, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 3: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonistsGregory A Gfesser, Henry Zhang, Jurgen Dinges, et al.
Journal of Medicinal Chemistry|August 8, 2008
The alkaloid conessine and analogues as potent histamine H3 receptor antagonistsChen Zhao, Minghua Sun, Youssef L Bennani, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 4, 2008
Emergency department utilization patterns among older adultsFredric D Wolinsky, Li Liu, Thomas R Miller, et al.
Chiropractic & Osteopathy|September 8, 2007
The use of chiropractors by older adults in the United StatesFredric D Wolinsky, Li Liu, Thomas R Miller, et al.
Biochemical Pharmacology|August 6, 2004
Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonistTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like propertiesTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
Neuropharmacology|July 5, 2005
2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonistMasaki Nakane, Marlon D Cowart, Gin C Hsieh, et al.
Pharmacology, Biochemistry, and Behavior|December 17, 2009
H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in ratsGin C Hsieh, Prasant Chandran, Anita K Salyers, et al.
Journal of Medicinal Chemistry|September 27, 2008
Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation modelsMarlon D Cowart, Robert J Altenbach, Huaqing Liu, et al.
Journal of Medicinal Chemistry|October 9, 2007
Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonistsRobert J Altenbach, Huaqing Liu, Patricia N Banfor, et al.
Pageof 8